Vimarsana
Biggest News Aggregation in the World

Page 4 - Rob Volansky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rob Volansky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rob Volansky Today - Breaking & Trending Today

'Therapeutic headway' still lacking for rare VEXAS disease - Vimarsana News

'Therapeutic headway' still lacking for rare VEXAS disease

Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio VEXAS syndrome is a recently discovered disease that features fever, orchitis, skin nodules and small- or medium-vessel vasculitis, among other symptoms, according to a presenter at the Biologic Therapies Summit. Peter Grayson, MD , head of the vasculitis translational research program and associate director of the NIAMS Fellowship Program, offered clinicians tips on recognizing this complex, clinically challenging and fr...

Source: healio.com
Tocilizumab holds firm as steroid-sparing agent in giant cell arteritis - Vimarsana News

Tocilizumab holds firm as steroid-sparing agent in giant cell arteritis

Tocilizumab holds firm as steroid-sparing agent in giant cell arteritis Source: Warrington K. When should biologic agents be introduced in giant cell arteritis and for how long should they be given? Presented at: Biologic Therapies Summit IX; May 21-23, 2021 (virtual meeting). Disclosures: Warrington reported no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALER...

Source: healio.com
OARSI Joint Effort Initiative seeks to improve remote, online care in COVID-19 setting - Vimarsana News

OARSI Joint Effort Initiative seeks to improve remote, online care in COVID-19 setting

OARSI Joint Effort Initiative seeks to improve remote, online care in COVID-19 setting Source: Quicke. The OARSI "Joint Effort Initiative" Repository of Online Osteoarthritis Management Programmes: An Implementation Rapid Response During COVID-19. Presented at: OARSI 2021 World Congress on Osteoarthritis; April 29-May 1. (virtual meeting). Disclosures: Quicke reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles ar...

Source: healio.com
'No need' to suspend immunosuppressive drugs due to COVID-19: No impact on risk outcomes - Vimarsana News

'No need' to suspend immunosuppressive drugs due to COVID-19: No impact on risk outcomes

Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio It is only natural that individuals taking immunosuppressive medications would fear COVID-19. However, recent findings add to a growing body of data indicating that immunosuppression may not elevate risk for worse outcomes for COVID-19 hospitalization. “This is a small amount of good news at a time in this pandemic when we need it,” G. Caleb Alexander, MD, MS , told H ealio Rheumatology. “Doctors and patient...

Source: healio.com